Psychedelics
Cannabis Use at All-Time-High in US, Finds NIH Survey
Cannabis and hallucinogens are more popular than ever in the US, according to an ongoing National Institutes of Health (NIH) survey.
Psilocybin Is Safe to Give to Anorexic Patients, Trial Finds
Researchers gave the ‘magic mushroom’ drug to ten participants with anorexia, who then received follow-up psychological support.
FDA Releases Draft Guidance For Psychedelic Drugs Research
Comments from the public and relevant professionals are welcome and will be accepted until August 25.
What Are Synthetic Psychedelics?
In a panel discussion last year, Analytical Cannabis brought together five experts on psychedelics to discuss these new psychedelic NCEs, and to provide new perspectives on the future of the psychedelic drug development landscape.
Uncovering the Mechanisms of Action of Psychedelic Drugs
Psychedelics can be classified into three main groups, but how does each type affect the brain?
No Differences Between Equivalent Doses of LSD, Mescaline, and Psilocybin, Study Finds
There are no significant differences in the effects of LSD, mescaline, or psilocybin when given at equivalent doses, according to a new study.
Ketamine Treats Pain By Treating Depression, Study Suggests
The study involved over 300 chronic pain patients who received more than one infusion of ketamine over several months. All participants reported pain relief; those with depression experienced “more robust” relief.
Psilocybin Temporarily Improves Man’s Color Blindness, Report Claims
The report, published in the journal Drug Science, Policy and Law, details the experiences of a 35-year-old man who had been diagnosed with a mild case of red-green color blindness five years earlier.
Oregon Regulator Licenses State’s First Psilocybin Lab
Oregon voters approved a ballot measure to legalize psilocybin mushrooms for therapy sessions back in November 2020.
